| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 10/06/1999 | EP0946561A1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments |
| 10/06/1999 | EP0946528A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 10/06/1999 | EP0946519A1 Benzamide derivatives having a vasopressin antagonistic activity |
| 10/06/1999 | EP0946517A1 N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application |
| 10/06/1999 | EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 10/06/1999 | EP0946508A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 10/06/1999 | EP0946185A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND |
| 10/06/1999 | EP0946178A1 Combination therapy for reducing the risks associated with cardiovascular disease |
| 10/06/1999 | CN1230993A Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
| 10/06/1999 | CN1230956A Method of producing polyphenol-containing compositions |
| 10/06/1999 | CN1230875A Flavonol containing food supplements |
| 10/06/1999 | CN1230414A Medicine for preventing cerebral thrombus |
| 10/05/1999 | US5962695 Aromatic amidine derivatives and salts thereof |
| 10/05/1999 | US5962693 Catalytic hydrogenation |
| 10/05/1999 | US5962660 Compound which suppresses selectin-mediated cellular adhesion; for stable antiinflammatory agents with better bioavailability and greater activity which are easier to synthesize |
| 10/05/1999 | US5962650 Oxygen-reduced aqueous solution of factor VIII |
| 10/05/1999 | US5962529 Metalloproteinase inhibitors |
| 10/05/1999 | US5962448 Pyrroloazepine derivatives |
| 10/05/1999 | US5962439 Cardiovascular disorder |
| 10/05/1999 | US5962420 Wound healing agents; drug delivery; crosslinking fibrin |
| 10/05/1999 | US5962418 Factor VII-derived peptides |
| 10/05/1999 | US5962408 Disulphide-cyclo- H-Cys-Glu-Gln-Tyr-Cys-OH!, and its use in blood-clotting disorders |
| 10/05/1999 | US5962299 Adding a salt buffer, a sodium salt, at least one amino acid, and albumin and/or nonionic surfactant to protein c or activated protein c; for storage stability of anticoagulant |
| 10/05/1999 | US5962266 Protease inhibitor peptides |
| 10/05/1999 | US5962026 Solid compositions of fibrin monomer |
| 09/30/1999 | WO1999049072A1 Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid |
| 09/30/1999 | WO1999048870A1 Piperididinyl and n-amidinopiperidinyl derivatives |
| 09/30/1999 | WO1999048533A1 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
| 09/30/1999 | WO1999048522A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 09/30/1999 | WO1999040198A3 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 09/30/1999 | WO1999037325A3 Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
| 09/30/1999 | WO1999035266A3 Human urotensin ii |
| 09/30/1999 | WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 09/30/1999 | CA2324566A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 09/30/1999 | CA2233725A1 Hemoglobin-hydroxyethyl starch complexes |
| 09/29/1999 | EP0944650A1 Antithrombotic peptides derived from fibronectin type ii repeats |
| 09/29/1999 | EP0944645A1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME |
| 09/29/1999 | EP0944631A1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases |
| 09/29/1999 | EP0944619A1 Novel integrin receptor antagonists |
| 09/29/1999 | EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use |
| 09/29/1999 | EP0944590A2 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 09/29/1999 | EP0944386A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 09/29/1999 | CN1229677A Composition and methods using nitroxides to avoid oxygen toxicity |
| 09/28/1999 | US5958952 Substituted phenylamindines, medicaments containing these compounds and process for producing them |
| 09/28/1999 | US5958943 A!-anellated pyrrole derivatives and their use in pharmacology |
| 09/28/1999 | US5958924 Hypotensive agents, cardiovascular disorders, antiischemic agents, restenosis, anticoalugants, respiratory system disorders |
| 09/28/1999 | US5958918 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N- (aminominomethyl)phenylalkyl!-azaheterocyclylamide compounds |
| 09/28/1999 | US5958916 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 09/28/1999 | US5958899 Polysaccharides having a high iduronic acid content |
| 09/28/1999 | US5958732 Anticoagulants in snake venom |
| 09/28/1999 | US5958731 Cell junction PDZ protein |
| 09/28/1999 | US5958726 Polynucleotide sequence of clone h84924 accession number atcc 98028; has signal sequence; for diagnosis and treatment of related diseases |
| 09/28/1999 | US5958400 Isolated polypeptide comprising specified amino acid sequence |
| 09/28/1999 | US5958250 Blood processing systems and methods which optically derive the volume of platelets contained in a plasma constituent |
| 09/23/1999 | WO1999047675A1 Mu-1, member of the cytokine receptor family |
| 09/23/1999 | WO1999047545A2 Inhibitors of caspases |
| 09/23/1999 | WO1999047538A1 Cytokine receptor common gamma chain like |
| 09/23/1999 | WO1999047151A1 Peptide ligands for the erythropoietin receptor |
| 09/23/1999 | WO1999040106A3 Use of angiotensin analogues for promoting erythropoiesis |
| 09/23/1999 | DE19802139C1 Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung A monoclonal antibody specific for activated coagulation factor VII and its use |
| 09/23/1999 | CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/22/1999 | EP0943616A1 Substituted imidazole derivatives and their use as cytokine inhibitors |
| 09/22/1999 | EP0943606A1 Benzenesulfonamide derivatives and drugs containing the same |
| 09/22/1999 | EP0942996A1 Thrombolytic agents with antithrombotic activity |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942959A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 09/22/1999 | EP0942932A1 Multimeric erythropoietin with increased biological activity |
| 09/22/1999 | EP0942931A2 Modulation of interactions between myosin and integrins |
| 09/22/1999 | EP0942899A1 Manufacturing process of metoprolol |
| 09/22/1999 | EP0771324B1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 09/22/1999 | EP0726764B1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 09/22/1999 | CN1229414A Multivalent compounds for cross-linking receptors and uses thereof |
| 09/22/1999 | CN1229357A Method of inhibiting fibrosis with growth inhibition excitant |
| 09/22/1999 | CN1229136A Long-noded pit viper enzyme and producing technology thereof |
| 09/22/1999 | CN1228962A Composition and methods using nitroxides to avoid oxygen toxicity |
| 09/22/1999 | CN1228959A Erigeron breviscopus element soft capsule and production method thereof |
| 09/21/1999 | US5955576 Peptide aldehyde analogs that inhibit thrombin or factor xa; for prevention or treatment of abnormal thrombosis |
| 09/21/1999 | US5955492 Carboxylic acid indole inhibitors of chemokines |
| 09/21/1999 | US5955474 Antiedema agents or diuretic antagonist |
| 09/21/1999 | US5955447 Administering as anticoagulant; treating cardiovascular disorders |
| 09/21/1999 | US5955433 Method of thrombin inhibition |
| 09/21/1999 | US5955357 In-vitro-derived human neutrophil precursor cells |
| 09/21/1999 | US5955072 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide |
| 09/21/1999 | CA2135751C 4-mercaptoacetylamino-¬2| benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
| 09/21/1999 | CA2073741C Thromboplastin extract, reagent, and preparation thereof |
| 09/16/1999 | WO1999046289A1 31 human secreted proteins |
| 09/16/1999 | WO1999046281A2 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | WO1999046274A1 Modified factor viii |
| 09/16/1999 | WO1999046272A1 Serine peptidase modulators |
| 09/16/1999 | WO1999046268A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 09/16/1999 | WO1999046262A1 Benzofurylpyrone derivatives |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046245A2 PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL |
| 09/16/1999 | WO1999045953A1 Heparin cofactor ii-containing compositions and method for stabilizing the same |
| 09/16/1999 | WO1999045945A1 Improved radiation therapy methods |
| 09/16/1999 | WO1999045941A1 Peptide compositions and formulations and use of same |
| 09/16/1999 | WO1999045939A1 Fibrinogen receptor antagonists |
| 09/16/1999 | WO1999045938A1 Thrombin preparation and products and fibrin sealant methods employing same |
| 09/16/1999 | WO1999045936A1 Supercritical conditioned gas mixture containing co2, no and optionally a neutral gas |
| 09/16/1999 | WO1999045913A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions |